Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication

Hepatocellular carcinoma (HCC) arises in the background of chronic liver diseases, including hepatitis and liver cirrhosis caused by hepatitis C virus (HCV) infection. It is well known that HCV eradication using antiviral drugs can efficiently inhibit hepatocarcinogenesis. Recent advances in and dev...

Full description

Bibliographic Details
Main Authors:	Natsumi Oe, Haruhiko Takeda, Yuji Eso, Atsushi Takai, Hiroyuki Marusawa
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Pathogens
Subjects:	hepatitis C virus liver cancer SVR
Online Access:	https://www.mdpi.com/2076-0817/11/4/430

Similar Items

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
by: Masahito Nakano, et al.
Published: (2019-05-01)

Genetic Landscape of Multistep Hepatocarcinogenesis
by: Haruhiko Takeda, et al.
Published: (2022-01-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
by: Anca Trifan, et al.
Published: (2023-02-01)

Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma
by: Eun-Sook Park, et al.
Published: (2022-07-01)

Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study
by: Umut Devrim Binay, et al.
Published: (2023-05-01)

Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers
by: Kenji Imai, et al.
Published: (2021-11-01)

Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
by: Waleed Attia Hassan, et al.
Published: (2023-10-01)

Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma
by: Zhiyong Du, et al.
Published: (2023-05-01)

An Update on Hepatocellular Carcinoma in Chronic Kidney Disease
by: Fabrizio Fabrizi, et al.
Published: (2021-07-01)

Hepatitis E
by: Ozzie Anis
Published: (2019-07-01)

Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection
by: Tasuku Nakabori, et al.
Published: (2022-05-01)

Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies
by: Aleksei Suslov, et al.
Published: (2022-11-01)

Clinical study of lenvatinib in the treatment of hepatitis virus-related hepatocellular carcinoma and antiviral therapy
by: Xiaomi Li, et al.
Published: (2023-01-01)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
by: Chen Shen, et al.
Published: (2023-01-01)

Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
by: Hyung Joon Yim, et al.
Published: (2024-02-01)

Co occurrence of Hepatitis B Virus Infection and Autoimmune Hepatitis with Marked Hepatitis B Virus Replication Following Treatment of Autoimmune Hepatitis
by: Tyagi I, et al.
Published: (2015-10-01)

Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic Individuals
by: Angelo Armandi, et al.
Published: (2022-08-01)

Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection
by: Tsai-Hsuan Yang, et al.
Published: (2023-02-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
by: Yuji Eso, et al.
Published: (2021-10-01)

Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma
by: Marco Y. W. Zaki, et al.
Published: (2022-02-01)

Safety and Efficacy of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C in Population Aged 60 Years and Older in Upper Egypt
by: Ali A. Ghweil, et al.
Published: (2023-01-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)

Hepatitis C Virus and Hepatocellular Carcinoma
by: Masao Omata, et al.
Published: (2013-01-01)

Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma
by: Tomoyuki eHonda, et al.
Published: (2016-05-01)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
by: Saba Khaliq, et al.
Published: (2018-11-01)

Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus
by: Shuling Wu, et al.
Published: (2023-01-01)

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?
by: Mustafa Kemal ÇELEN, et al.
Published: (2018-06-01)

Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents
by: Pin-Nan Cheng, et al.
Published: (2023-03-01)

Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
by: Marwa Hassan, et al.
Published: (2023-06-01)

Insights into the impact of hepatitis B virus on hepatic stellate cell activation
by: Hongjuan You, et al.
Published: (2023-04-01)

Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study
by: Maria Lucia Gomes Ferraz, et al.
Published: (2023-07-01)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
by: Nicholas Noverati, et al.
Published: (2022-04-01)

The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
by: Leigh P. Johnson, et al.
Published: (2020-04-01)

Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children
by: Chaowapong Jarasvaraparn, et al.
Published: (2024-02-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
by: Nobuharu Tamaki, et al.
Published: (2022-03-01)

Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma
by: Yu-Chen Tseng, et al.
Published: (2023-12-01)

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Yuji Eso, et al.
Published: (2019-03-01)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
by: Maria Bousali, et al.
Published: (2021-08-01)